The weekly litigation news digest is live. Subscribe now

IP Verse

Hyaluronic Acid Gels Crosslinked By Sodium Trimetaphosphate - EP3166652

The patent EP3166652 was granted to Allergan Industrie on Apr 3, 2019. The application was filed on Jul 11, 2014 under application number EP14802113A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3166652

ALLERGAN INDUSTRIE
Application Number
EP14802113A
Filing Date
Jul 11, 2014
Status
Opposition Rejected
Apr 27, 2024
Publication Date
Apr 3, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
LABORATOIRES VIVACYJan 3, 2020TRIPOZADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONWO2014181147
INTERNATIONAL-SEARCH-REPORTWO2014013286
OPPOSITIONUS2003148995
OPPOSITIONUS5783691
OPPOSITIONWO2009047347
OPPOSITIONWO2014181147

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents